TeselaGen Biotechnology has secured a National Science Foundation Small Business Innovation and Research grant to pursue “A Synthetic Biology Design-Build-Test Platform for Automated Combinatorial DNA Assembly”. The grant focuses on the first part of TeselaGen’s Design, Build, Test, Evolve approach to biomolecule design. According to TeselaGen CEO Michael Fero “We decided to put the design principles of Synthetic Biology to the test, building our software framework along lines that model the forward engineering approach, while not ignoring the special ability of biological systems to design themselves through evolutionary mechanisms”
TeselaGen Wins NSF SBIR Award
TeselaGen Team
